Division of Biochemistry and Molecular Biology, Department of Agrochemistry and Biochemistry, Faculty of Sciences, University of Alicante, 03690 Alicante, Spain.
Applied Biochemistry Research Group AppBiochem, University of Alicante, 03690 Alicante, Spain.
Int J Environ Res Public Health. 2020 Jun 16;17(12):4294. doi: 10.3390/ijerph17124294.
Down syndrome (DS) is related to diseases like congenital heart disease, obstructive sleep apnea, obesity and overweight. Studies focused on DS associated with obesity and overweight are still scarce. The main objective of this work was to analyze the relationship between dietary intervention, physical exercise and body composition, in DS with overweight and obesity. This review is based on the PRISMA guidelines (Preferred Reporting Items for Systematic reviews and Meta-Analyses). Selection criteria for this analysis were: publications between January 1997 and December 2019; DS individuals with overweight and obesity; clinical trials using dietary intervention and physical exercise paying attention to changes in body composition. Selected clinical trials were focused on an exclusive intervention based on physical exercise. The anthropometric measures analyzed were body fat, BMI, waist circumference, body weight and fat free mass. The main conclusion is that prescribing structured physical exercise intervention may be related to a greater variation in body composition. Despite limited number of clinical trials analyzed, it can be assumed that the reported studies have not achieved optimal results and that the design of future clinical trials should be improved. Some guidelines are proposed to contribute to the improvement of knowledge in this field.
唐氏综合征(DS)与先天性心脏病、阻塞性睡眠呼吸暂停、肥胖和超重等疾病有关。目前针对 DS 相关肥胖和超重的研究仍然较少。本研究的主要目的是分析饮食干预、体育锻炼和身体成分在超重和肥胖 DS 中的关系。本综述基于 PRISMA 指南(系统评价和荟萃分析的首选报告项目)。本分析的选择标准为:1997 年 1 月至 2019 年 12 月发表的出版物;超重和肥胖的 DS 个体;采用饮食干预和体育锻炼的临床试验,重点关注身体成分的变化。选择的临床试验主要针对基于体育锻炼的专门干预。分析的人体测量指标包括体脂肪、BMI、腰围、体重和去脂体重。主要结论是,规定结构化的体育锻炼干预可能与身体成分的更大变化有关。尽管分析的临床试验数量有限,但可以假设报告的研究尚未取得最佳结果,未来临床试验的设计应加以改进。提出了一些建议,以促进该领域知识的发展。